|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Aug―05 |
Impact of Statin or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker on In-Hospital Mortality of COVID-19 Patients |
Mohsen Gholinataj Jelodar, Samaneh Mirzaei, Majid Haji Maghsoudi |
2 |
[GO] |
2024―Jul―06 |
Early Outpatient Administration of Remdesivir Shortens Recovery Time in Patients with Mild to Moderate COVID-19 |
Majid Hajimaghsoudi, Fatemeh Saghafi, Mahya Shorabi, Samaneh Mirzaei, Mehrnaz Moharami, Negin Daryaei, et al. (+5) Farahnaz Hoseinzade, Farzad Jalili, Hamid Reza Rezaei, Yekta Rameshi, Mohsen Gholinataj Jelodar |
3 |
[GO] |
2024―Jul―06 |
Unusual Extra Pulmonary Clinical Manifestation as Initial Presenting Feature of COVID-19 and its Management: A Systematic Review of Case Reports |
Priyanka Pravinbhai Hotha, Rachna Gupta |
4 |
[GO] |
2024―Jul―06 |
Evaluation of Adverse Drug Events of Remdesivir for the Treatment of COVID-19 in Patients Contacting the 13-Aban Pharmacy Drug and Poison Information Center |
Amirhosein Ghahremanian, Hasti Photography, Sona Ghasemi, Mohammadreza Heidari, Elliyeh Ghadrdan |
5 |
[GO] |
2024―Jul―06 |
The Evaluation of Remdesivir Utilization Pattern and Its Correlation with Clinical Indicators in Hospitalized Patients During COVID-19 Pandemic; A Retrospective Cross-sectional Study |
Yasaman Soroush, Hadi Esmailyi, Nasibeh Ghalandari |
6 |
[GO] |
2024―Jul―06 |
Retrospective Observational Analysis of Tocilizumab Outcomes in COVID-19 Patients at a Tertiary Care Hospital |
Vrushali Aringale, Bharti Daswani, Madeline Fernandes |
7 |
[GO] |
2024―Jul―06 |
Third Nerve Palsy: Rare Adverse Event following Covid-19 Vaccination |
Indira B Deshmukh, Sheyas R Burute, Shraddha Pore, Atmik Singh |
8 |
[GO] |
2024―Jul―06 |
Oral Hydroalcoholic Extract of Licorice for Management of Mild to Moderate Coronavirus Disease-19 Patients: A Double-Blind Randomized Clinical Trial |
Adeleh Jeddi, Amir Hooshang Mohammadpour, Milad Iranshahy, Ali Moradi, Batool Zarei |
9 |
[GO] |
2024―Jul―06 |
A Case Series of Eight Mucormycosis Patients during SARS-CoV-2 -Pandemic |
Hedyieh Karbasforooshan, Batool Zarei, Mahdi Jannati, Ghazaleh Elahabadi, Sepideh Elyasi, Ali Akbar Heydari |
10 |
[GO] |
2023―May―03 |
Clustering of Deceased Patients with COVID-19 in Iran Based on Clinical Features in Hospitalization |
Elnaz Shaseb, Saba Ghaffary, Haleh Vaez, Parvin Sarbakhsh, Elnaz Khani |
11 |
[GO] |
2023―May―03 |
Aggressive Behavior in a Critically Ill COVID-19 Patient: Possible Role of Medication Discrepancies |
Negar Javidmehr, Vahid Reisi-Vanani, Mina Borran |
12 |
[GO] |
2023―Jan―02 |
Study of Drug Utilization Pattern during Second Wave of Covid-19 in a Tertiary Care Centre: A Retrospective Cross Sectional Study |
Ujwala P. Gawali, Aruna Gurung |
13 |
[GO] |
2022―Oct―08 |
Evaluating the Effects of Clinical Characteristics and Therapeutic Regimens on Mortality in Hospitalized Patients with Severe COVID-19 |
Elahe Karimpour-razkenari, Javad Boskabadi, Monireh Ghazaeian, Hamidreza Samaee, Hanieh Azizi, Fatemeh Esfandiari, et al. (+3) Seyed Abdollah Mousavi, Sahar Fallah, Sekineh Talebi |
14 |
[GO] |
2022―Oct―08 |
Safety and Effectiveness of Molnupiravir in Covid-19 Treatment: A Rapid Review |
Mohammadreza Mobinizadeh, Ali Akbarisari, Alireza Olyaeemanesh, Marita Mohammadshahi, Elham Ahmadnezhad, Parisa Aboee, et al. (+2) Zeinab Fakorfard, Raheleh Sadeghi |
15 |
[GO] |
2022―Oct―08 |
A Case Report of Three Guillain-Barré Syndrome During SARS-CoV-2 Pandemic: Promising Outcome in a Patient with History of Multiple Sclerosis |
AmirAli Ghahremani, Amir Bigdeli, Davoud Salarbashi, Pouyan Shakouri, Sepideh Elyasi |
16 |
[GO] |
2022―Jul―05 |
High Prevalence of Potential Drug-Drug Interactions Among Patients Treated with Off-label Therapies for COVID-19 |
Allan Ramos-Esquivel, Cristina Fernández, Luis Garro-Zamora, Ana Victoria Chaves, Álvaro Viquez-Jaikel |
17 |
[GO] |
2022―Jul―05 |
Plant-Derived Metabolites as Potent Inhibitor and Treatment for COVID-19 |
Roghaieh Holghoomi, Arash Abdolmaleki, Asadollah Asadi, Mahan Kajkolah, Krishnamoorthy Gurushankar, Mahmoud Bidarlord |
18 |
[GO] |
2022―Apr―09 |
Challenges of Blood Transfusions in β-Thalassemia during COVID-19 Pandemic in Low Middle-Income Country |
Kashif Ali, Kashif Rizvi, Saqib Hussain Ansari, Faisal Zahid |
19 |
[GO] |
2022―Apr―09 |
Evaluation of the Possible Effect of the Influenza Vaccine on the Severity, Mortality, and Length of Hospitalization among Unvaccinated COVID-19 Patients; An Observational, Cross-Sectional Study |
Nafiseh Alizadeh, Fatemeh Sadat Tabatabaei, Mina Borran, Mehrnoush Dianatkhah, Amirali Azimi, Seyedeh Nafise Forghani, et al. (+4) Samaneh Akbarpour, Mahboubeh Alizadeh, Sara Torabi, Neda Faraji |
20 |
[GO] |
2022―Apr―09 |
Effects of Pulse Dose of Corticosteroids in Hospitalized Patients with COVID-19: An Observational Study |
Hadis Nikpour, Fatemeh Heydarpour, Siavash Vaziri, Mohammad Hossein Zamanian, Foroud Shahbazi |
21 |
[GO] |
2022―Jan―04 |
Cognitive Consequences of COVID-19: The Missing Piece of Pandemic Crisis |
Fatemeh Mohammadian, Niayesh Mohebbi |
22 |
[GO] |
2022―Jan―04 |
How to Increase the Immunogenicity of SARS-COV-2 Inactivated Vaccines? |
Yousef Khadivi |
23 |
[GO] |
2022―Jan―04 |
The Impact of New Coronavirus on Cancer Patients |
Aida Karimian, Sona Talaei, Arash Abdolmaleki, Asadollah Asadi, Muhammad Akram, Hussein A. Ghanimi |
24 |
[GO] |
2021―Oct―12 |
Behavioral, Environmental and Pharmacotherapy Challenges in Dementia during COVID-19 Pandemic: Solutions and Management Issues |
Fatemeh Mohammadian, Marjan Moghadamnia, Ali Talebi, Niayesh Mohebbi |
25 |
[GO] |
2021―Oct―12 |
Clinical Pharmacists: Practitioners Who Are Essential Members to Enhance Pharmaceutical Care During Covid-19 Pandemic |
Niayesh Mohebbi, Amir Rezazadeh |
26 |
[GO] |
2021―Oct―12 |
Efficacy and Safety of Interferon Beta-1b in the Management of Patients with COVID-19: A Prospective, Open-Label, Non-Randomized Trial |
Nima Rouhani, Elahe Karimpour-razkenari, Mostafa Alizadeh Forutan, Monireh Ghazaeian, Ebrahim Salehifar, Mohammad Sadegh Rezai, Sahar Fallah |
27 |
[GO] |
2021―Oct―12 |
A Review of Severe Acute Respiratory Syndrome Coronavirus 2 and Pathological Disorders in Patients |
Ghorbat Saleh Ali, Betul Ozdemir, Zeliha Selamoglu |
28 |
[GO] |
2021―Jul―04 |
The Rational Use of Medicines (RUM) in Coronavirus Disease 2019 (COVID-19) |
Zahra Karimian |
29 |
[GO] |
2021―Jul―04 |
Potential Drug-Drug Interactions among Hospitalized COVID-19 Patients Admitted to Medical Wards of a Referral Hospital, North-East of Iran: A Cross Sectional Study |
Niloofar Saber-Moghaddam, Sepideh Hejazi, Sepideh Elyasi |
30 |
[GO] |
2021―Jan―23 |
Assessment of Training of Community Pharmacists towards the Prevention of COVID-19 in a North Central State of Nigeria |
Olayinka Stephen Ilesanmi, Aanuoluwapo Adeyimika Afolabi, Oluwatosin Enoch Fakayode, Stephen Arigidi, Barakat Olatayo Olanrewaju |
31 |
[GO] |
2020―Nov―07 |
Molecular Mechanisms of Galidesivir as a Potential Antiviral Treatment for COVID-19 |
Mahshid Ataei, Hesamoddin Hosseinjani |
32 |
[GO] |
2020―Nov―07 |
The Controversies Surrounding Tocilizumab Administration Following Pathogen-Associated Molecular Pattern (PAMP) Induced by COVID-19 |
Shayesteh Gheibi, Farhad Najmeddin, Bita Shahrami, Kourosh Sadeghi, Mojtaba Mojtahedzadeh |
33 |
[GO] |
2020―Nov―07 |
Novel Immunological Aspects of Sirolimus as a New Targeted Therapy for COVID-19 |
Mahshid Naserifar, Hesamoddin Hosseinjani |
34 |
[GO] |
2020―Nov―07 |
Effect of COVID-19 Infection on the Immune System and Risk of Developing Diabetes Complications: A Review |
Samir Derouiche, Cheradid Taissir, Djoumana Abdelmalek, Ikram Achi |
35 |
[GO] |
2020―Nov―07 |
The Shifting Landscape of Pharmaceutical Care-During and Beyond the COVID-19 Pandemic |
Zahra Karimian, Kheirollah Gholami |
36 |
[GO] |
2020―Aug―01 |
COVID-19: The Biggest Medical and Pharmaceutical Challenge of the 21st Century |
Kourosh Sadeghi |